BeiGene's Project Finance Round

BeiGene raised a round of funding on May 05, 2014. Investors include Merck & Co..

BeiGene is a Chinese oncology R&D company focused on discovering, developing and commercializing targeted and immune-oncology therapeutics through a novel translational research platform that combines…

Articles about BeiGene's Project Finance Round: